EUVIMEDEUVIMED entdecken
KommentarOpen Access

Genetic Screening, Cancer Syndromes, and the Radiologist

Peter L Choyke iD

Radiology: Imaging Cancer · 2024

DOI: 10.1148/rycan.240045 ↗

Kurz gefasst

Kommentar in der Zeitschrift Radiology: Imaging Cancer, 2024. Verfasst von Peter L Choyke. Beteiligte Einrichtung: From the Molecular Imaging Branch, National Cancer Institute, 10 Center Dr, Bldg 10, Room B3B69F, Bethesda, MD 20892. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsHumansEarly Detection of CancerPrevalenceGerm-Line MutationRadiologistsGenetic TestingProto-Oncogene ProteinsTumor Suppressor ProteinsUbiquitin Thiolesterase

Substanzen

FLCN protein, humanProto-Oncogene ProteinsTumor Suppressor ProteinsBAP1 protein, humanUbiquitin Thiolesterase

Autor:innen und Institutionen

  • From the Molecular Imaging Branch, National Cancer Institute, 10 Center Dr, Bldg 10, Room B3B69F, Bethesda, MD 20892.

ORCID-Profile: Peter L Choyke

Zitieren

APA

Choyke, P. L. (2024). Genetic Screening, Cancer Syndromes, and the Radiologist. Radiology: Imaging Cancer. https://doi.org/10.1148/rycan.240045

Vancouver

Choyke PL. Genetic Screening, Cancer Syndromes, and the Radiologist. Radiology: Imaging Cancer. 2024. doi:10.1148/rycan.240045

BibTeX
@article{Choyke2024,
  author = {Choyke, Peter L},
  title = {Genetic Screening, Cancer Syndromes, and the Radiologist},
  journal = {Radiology: Imaging Cancer},
  year = {2024},
  doi = {10.1148/rycan.240045}
}
Kostenlos starten →